May 1, 2026 Log in

News

[Formosa Pharmaceuticals] May 2026 Revenue Reaches NT$ 2.35 Million (Down 50.7% YoY)

Citation-Grade Primary-source linked Schema.org verified NQ 31 / 100

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:09 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Biotech company Formosa Pharmaceuticals (6838) announced its May 2026 revenue of NT$ 2.35 million, representing a 50.7% year-on-year decrease.

Biotech company Formosa Pharmaceuticals (6838) announced its May 2026 revenue of NT$ 2.35 million, representing a 50.7% year-on-year decrease.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: May 1, 2026

Company Code: 6838 Company Name: Formosa Pharmaceuticals Industry: Biotechnology and Medical Care Data Period: May 2026 Monthly Revenue: NT$ 2,348 thousand (approx. NT$ 0.02 billion) YoY Change: -50.7%

This data represents the monthly revenue figures for Formosa Pharmaceuticals in May 2026. The company experienced a significant revenue decline compared to the same period last year.

FACT BOX

Source: PR Times
Category: News

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 12, 2026 1:41 PM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What is Formosa Pharmaceuticals' revenue for May 2026?

The monthly revenue was NT$ 2,348 thousand (approx. NT$ 0.02 billion), down 50.7% year-on-year.

What sector does Formosa Pharmaceuticals operate in?

It operates in the biotechnology and medical care sector in Taiwan.

What is the stock code of Formosa Pharmaceuticals?

Its stock ticker code is 6838 in Taiwan.

Cite this article — HOW TO CITE

Washin AI News Desk“[Formosa Pharmaceuticals] May 2026 Revenue Reaches NT$ 2.35 Million (Down 50.7% YoY)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.washinmura.jp/ai/%E5%8F%B0%E6%96%B0%E8%97%A5/en/news/2026-05-01-%E5%8F%B0%E6%96%B0%E8%97%A5-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-0-02%E5%84%84-%E5%B9%B4%E5%A2%9E-50-7

AI CRAWLER ACTIVITY

as of Jul 3, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4909k

last Jul 3, 2026

GPTBot

bot_visits_summary

3238k

last Jul 3, 2026

Bingbot

bot_visits_summary

1987k

last Jul 3, 2026

Google AI

bot_visits_summary

1795k

last Jul 3, 2026

Googlebot

bot_visits_summary

1316k

last Jul 3, 2026

Applebot

bot_visits_summary

950k

last Jul 3, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 台新藥 Back to newsroom (59)

Copied